International Postgraduate Course in Genomics

Universitat Autònoma de Barcelona

Bellaterra (Barcelona), June 1-15, 2004

 

 

Pieter J. de Jong

(Children’s Hospital Oakland research Institute, Oakland, California)

 

 

Education and training

  • M.S. at Technische Hogeschool, Deft, The Netherlands (1976). Biochemical Engineering
     

  • Ph.D. at Rijksuniversiteit Utrecht, The Netherlands (1982). Molecular Biology

 

Professional Experience:

  • 1974               
Research Assistant, Hebrew University of Jerusalem, Israel.
 
  • 1976-1982
 Research Assistant, State University of Utrecht, The Netherlands.
 
  • 1982-1983
Research Associate, Albert Einstein College of Medicine, Bronx, NY.
 
  • 1983-1986
 Visiting Fellow, NIH, NIEHS, Research Triangle Park, NC.
 
  • 1986-1993
 Senior Biomedical Scientist, Lawrence Livermore National Laboratory.
 
  • 1991-1995
 Editorial Board for PCR Methods & Applications, Cold Spring Harbor Laboratory Press.
 
  • 1994-2000
 Editorial Board for Cytogenetics & Cellular Genetics
 
  • 1993-1999
Cancer Research Scientist, Roswell Park Cancer Institute, Buffalo, NY.
 
  • 1995-2002
 Associate Research Professor, Department of Cell & Molecular Biology, SUNY-Buffalo.
 
  • 1998-1999
 Acting-Chairman & Chairman, Department of Cancer Genetics. Roswell Park Cancer Institute, Buffalo.
 
  • 1999-2000
 Director, Molecular Biology, Park Davis Laboratory for Molecular Genetics, Alameda, CA.
 
  • 2000-2001 (Jan)
 Director, Molecular Biology, Pfizer Global Research & Development Alameda Laboratories
 
  • 2000-2001 (Jan)
 Guest Scientist, Children's Hospital Oakland Research Institute, Oakland, CA.
 
  • 2001-present
Research Scientist, Children's Hospital Oakland Research Institute, Oakland, CA.

 

Societies and Honors:

  • 1984-present
 American Association for the Advancement of Science
 
  • 1988-present
 American Society for Human Genetics
 
  • 1992
 Press release: discovery of the molecular defect responsible for myotonic dystrophy by my research group in close collaboration with several international research groups
 
  • 1992
 Ad-hoc member the Joint Working Group on the Mouse, Washington DC.
 
  • 1996-1998
 International Strategy meetings on the Human Genome Project at Bermuda
 
  • 1997
 NCI Panel on the future of Tumor Cytogenetics
 
  • 1998
 NIH Priority Setting Meeting for Mouse Resources
 
  • 1999
 Princeton meeting to plan the sequencing of the mouse genome
 
  • 2001
 Science Magazine, Vol. 291, p.1185: honored as "Unsung Hero of the Human Genome Project"

 

References:

Pieter J. de Jong publications at PubMed.

 

Contact:

pdejong@chori.org